Clinical trial
Randomized Trial of Docetaxel and Gemcitabine Versus Gemcitabine in Elderly…
NCT00442026 · Hellenic Oncology Research Group, Other · Terminated
Key facts
| NCT number | NCT00442026 |
|---|---|
| Title | Randomized Trial of Docetaxel and Gemcitabine Versus Gemcitabine in Elderly Patients With NSCLC |
| Official title | A Multicenter Randomized Phase III Study of the Docetaxel and Gemcitabine Combination Versus Monotherapy With Gemcitabine as First-line Treatment in Elderly Patients With Advanced Non-Small-Cell Lung Cancer (NSCLC) |
| Lead sponsor | Hellenic Oncology Research Group, Other |
| Collaborators | University Hospital of Crete |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Non-small-cell Lung Cancer |
| Intervention type | Drug |
| Interventions | Docetaxel, Gemcitabine |
| Enrollment | 106 |
| Start date | Dec 1, 2006 |
| Primary completion | May 1, 2010 |
| Completion | May 1, 2010 |
| First posted | Mar 1, 2007 |
| Last update posted | Jun 27, 2012 |
| Countries | Greece |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: